FIRST EXTENSION - GRANTED
granted
on 15 Aug 2024
Last Applicant/ Owned by
11099 North Torrey Pines Road, Suite 280
La Jolla
CA
92037
Serial Number
97716183 filed on 13th Dec 2022
Registration Number
N/A
Correspondent Address
Alyssa M Worsham
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
WAR-LOCK
Research and development in the field of covalent protein biologics; medical and scientific research in the field of cancer treatment and diagnosis; pharmaceutical research and development; research and development of pharmaceuticals and biologicals in the field of cancer therapeutics; research and development in the field of synthetic biology enabled covalent therapeutics and covalent protein dru Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Research and development in the field of covalent protein biologics; medical and scientific research in the field of cancer treatment and diagnosis; pharmaceutical research and development; research and development of pharmaceuticals and biologicals in the field of cancer therapeutics; research and development in the field of synthetic biology enabled covalent therapeutics and covalent protein drugs; research and development for the purpose of selective covalent modification of proteins; research and development in the field of oncology, namely, development of a biotechnology platform to create covalent protein biologics for treating cancer; research and development in the field of covalent protein drugs, namely, development of a platform technology for identification of small-molecule and biologic therapeutics for treating cancer and targeting tumors; conducting clinical trials for others in the field of cancer therapeutics; biotechnology testing services, namely, testing in the field of recombinant protein production and bioconjugation; research and development services in the field of antibody-drug conjugates, T cells, natural killer (NK) cells, and macrophage engaging antibodies; research and development services for the purpose of antibody engineering, namely, custom design and engineering of antibodies
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical products, preparations, and substances for the treatment of cancer; cancer therapeutics, namely, anti-cancer preparations; novel cancer therapies, namely, pharmaceutical preparations and substances for the treatment of cancer and tumors; biological preparations and substances for the treatment, diagnosis, detection, and prevention of cancer; pharmaceutical products consisting of covalent protein biologic for the treatment of cancer and diseases in the nature of infectious diseases, viral diseases, autoimmune diseases, respiratory diseases, diseases of the central nervous system, and fibrotic diseases; pharmaceutical products, namely, covalent protein drugs for the treatment of cancer diseases; pharmaceuticals products consisting of synthetic biology enabled covalent protein biologic for the treatment of cancer and diseases in the nature of infectious diseases, viral diseases, autoimmune diseases, respiratory diseases, diseases of the central nervous system, and fibrotic diseases; pharmaceutical products consisting of covalent protein drugs for the treatment of cancer and diseases in the nature of infectious diseases, viral diseases, autoimmune diseases, respiratory diseases; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Chemicals for use in industry and science; reagents for use in scientific apparatus for chemical or biological analysis; reagents for medical research, namely, for therapeutic drug development; antibody reagents for scientific purposes; in-vivo diagnostic reagents for scientific or research use; enzymes for scientific use; cell culture media for use in scientific research; active chemical ingredients for use in the manufacture of anti-cancer drugs; laboratory chemicals, namely, an antibody reagent used for the detection of cancerous tumors; antibodies for research use, namely, for therapeutic drug development
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97716183
Mark Type
No Service Mark
Attorney Docket Number
No 60801-TM1002
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 15th Aug 2024 | SOU EXTENSION 1 GRANTED |
| 15th Aug 2024 | SOU EXTENSION 1 FILED |
| 15th Aug 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 15th Aug 2024 | SOU TEAS EXTENSION RECEIVED |
| 12th Mar 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 16th Jan 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 16th Jan 2024 | PUBLISHED FOR OPPOSITION |
| 27th Dec 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 07th Dec 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 07th Dec 2023 | EXAMINER'S AMENDMENT ENTERED |